Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-036267
Filing Date
2024-11-26
Accepted
2024-11-26 16:08:49
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A nby20241125_defa14a.htm DEFA14A 15611
2 nby20241125_defa14aimg001.jpg GRAPHIC 4650
3 nby20241125_defa14aimg002.jpg GRAPHIC 1938
  Complete submission text file 0001437749-24-036267.txt   26009
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33678 | Film No.: 241503747
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)